tradingkey.logo

Upexi Inc

UPXI
2.040USD
0.000
收盤 12/15, 16:00美東報價延遲15分鐘
120.14M總市值
0.07本益比TTM

Upexi Inc

2.040
0.000

關於 Upexi Inc 公司

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Upexi Inc簡介

公司代碼UPXI
公司名稱Upexi Inc
上市日期Jun 24, 2021
CEOMarshall (Allan)
員工數量59
證券類型Ordinary Share
年結日Jun 24
公司地址3030 Rocky Point Drive
城市TAMPA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33607
電話17013535425
網址https://upexi.com/
公司代碼UPXI
上市日期Jun 24, 2021
CEOMarshall (Allan)

Upexi Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+17.08%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+68.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+17.08%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+68.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q1
業務USD
名稱
營收
佔比
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
地區USD
名稱
營收
佔比
United States of America
14.57M
98.25%
Other
259.57K
1.75%
業務
地區
業務USD
名稱
營收
佔比
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%

股東統計

更新時間: 11月22日 週六
更新時間: 11月22日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Polar Asset Management Partners Inc.
7.91%
Samara Special Opportunities
7.16%
GSR Growth Investments LP
4.25%
Marshall (Allan)
2.39%
Alyeska Investment Group, L.P.
1.98%
其他
76.30%
持股股東
持股股東
佔比
Polar Asset Management Partners Inc.
7.91%
Samara Special Opportunities
7.16%
GSR Growth Investments LP
4.25%
Marshall (Allan)
2.39%
Alyeska Investment Group, L.P.
1.98%
其他
76.30%
股東類型
持股股東
佔比
Hedge Fund
11.97%
Corporation
11.41%
Investment Advisor
8.44%
Individual Investor
6.08%
Research Firm
2.38%
Investment Advisor/Hedge Fund
1.36%
Bank and Trust
0.45%
Venture Capital
0.05%
其他
57.86%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
60
18.50M
31.42%
+11.94M
2025Q2
46
10.18M
21.50%
+7.63M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
2023Q3
40
369.15K
37.28%
-46.01K
2023Q2
44
368.80K
38.85%
-28.58K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Samara Special Opportunities
4.53M
7.69%
+4.53M
--
Aug 29, 2025
GSR Growth Investments LP
2.31M
3.92%
-1.00
-0.00%
Jun 30, 2025
Marshall (Allan)
1.51M
2.57%
+1.36M
+899.43%
Jul 16, 2025
Rudick (Brian Benjamin)
838.60K
1.42%
+400.00K
+91.20%
Jul 16, 2025
MMCAP Asset Management
12.94M
21.98%
+12.94M
--
Jul 16, 2025
The Vanguard Group, Inc.
500.84K
0.85%
+500.84K
--
Jun 30, 2025
Salkind (Gene)
585.37K
0.99%
+220.24K
+60.32%
Jul 16, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
公告日期
類型
比率
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1

常見問題

Upexi Inc的前五大股東是誰?

Upexi Inc的前五大股東如下:
Samara Special Opportunities
持有股份:4.53M
佔總股份比例:7.69%。
GSR Growth Investments LP
持有股份:2.31M
佔總股份比例:3.92%。
Marshall (Allan)
持有股份:1.51M
佔總股份比例:2.57%。
Rudick (Brian Benjamin)
持有股份:838.60K
佔總股份比例:1.42%。
MMCAP Asset Management
持有股份:12.94M
佔總股份比例:21.98%。

Upexi Inc的前三大股東類型是什麼?

Upexi Inc 的前三大股東類型分別是:
Polar Asset Management Partners Inc.
Samara Special Opportunities
GSR Growth Investments LP

有多少機構持有Upexi Inc(UPXI)的股份?

截至2025Q3,共有60家機構持有Upexi Inc的股份,合計持有的股份價值約為18.50M,占公司總股份的31.42% 。與2025Q2相比,機構持股有所增加,增幅為9.93%。

哪個業務部門對Upexi Inc的收入貢獻最大?

在FY2025,Internally manufactured業務部門對Upexi Inc的收入貢獻最大,創收9.26M,占總收入的62.48% 。
KeyAI